Iovera
Device Pain Management
PDI 00816287020071
General payments
$7,387,863
Research payments
$485,451
Through program year 2025, $7,387,863 in general payments and $485,451 in research payments were reported against Iovera (Pain Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,755,130 | 6,462 |
| 2025 | Research | $199,032 | 167 |
| 2024 | General | $1,778,514 | 9,226 |
| 2024 | Research | $286,418 | 108 |
| 2023 | General | $2,632,570 | 11,735 |
| 2022 | General | $1,221,649 | 4,259 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 99 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
31,682 general · 275 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.